Cargando…
The effect of ifosfamide, epirubicin, and recombinant human endostatin therapy on a cardiac angiosarcoma: A case report
RATIONALE: Cardiac angiosarcoma is a rare malignant tumor, for which only surgery has been proven to be effective to date. Currently there are no reports as to whether a postoperative regimen of ifosfamide, epirubicin, and recombinant human endostatin is effective. PATIENT CONCERN: The patient prese...
Autores principales: | Jiang, Lijun, Xu, Xingjie, Davies, Henry, Shi, Kexin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831325/ https://www.ncbi.nlm.nih.gov/pubmed/31027090 http://dx.doi.org/10.1097/MD.0000000000015290 |
Ejemplares similares
-
Antagonistic effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenovirus on homocysteine-induced vascular endothelial cells injury in vitro and in vivo
por: Cui, Zhen-Tian, et al.
Publicado: (2016) -
Relationship between thrombospondin-1, endostatin, angiopoietin-2, and coronary collateral development in patients with chronic total occlusion
por: Qin, Qing, et al.
Publicado: (2016) -
Neoadjuvant Ifosfamide and Epirubicin in the Treatment of Malignant Peripheral Nerve Sheath Tumors
por: Hirbe, Angela C., et al.
Publicado: (2017) -
Cardiac angiosarcoma: A case report and review of current treatment
por: Linfeng, Qian, et al.
Publicado: (2019) -
Effects of recombinant human brain natriuretic peptide combined with tolvaptan on cardiac and renal function and serum inflammatory factors in patients with severe heart failure
por: Yang, Jing, et al.
Publicado: (2023)